GLUE

Monte Rosa Therapeutics, Inc. (GLUE) is a pioneering biopharmaceutical company based in Boston, Massachusetts, focused on developing precision small molecule therapeutics that harness the body's inherent mechanisms for targeted protein degradation. Leveraging its proprietary technology platforms, Monte Rosa aims to address critical unmet medical needs across various therapeutic areas, notably in oncology and autoimmune diseases. With a robust pipeline of innovative drug candidates and a steadfast commitment to scientific excellence, the company is strategically positioned to transform treatment modalities and enhance patient outcomes through its groundbreaking approaches to drug discovery.